HPV Research Laboratory, UW Medicine, University of Washington, Seattle, Washington, United States of America.
PLoS One. 2011;6(12):e28423. doi: 10.1371/journal.pone.0028423. Epub 2011 Dec 14.
MicroRNA expression is severely disrupted in carcinogenesis, however limited evidence is available validating results from cell-line models in human clinical cancer specimens. MicroRNA-21 (mir-21) and microRNA-143 (mir-143) have previously been identified as significantly deregulated in a range of cancers including cervical cancer. Our goal was to investigate the expression patterns of several well-studied microRNA species in cervical samples and compare the results to cell line samples.
METHODOLOGY/PRINCIPAL FINDINGS: We measured the expression of mir-21 and mir-143 in 142 formalin-fixed, paraffin embedded (FFPE) cervical biopsy tissue blocks, collected from Dantec Oncology Clinic, Dakar, Senegal. MicroRNA expression analysis was performed using Taqman-based real-time PCR assays. Protein immunohistochemical staining was also performed to investigate target protein expression on 72 samples. We found that mir-21 expression increased with worsening clinical diagnosis but that mir-143 was not correlated with histology. These observations were in stark contrast to previous reports involving cervical cancer cell lines in which mir-143 was consistently down-regulated but mir-21 largely unaffected. We also identified, for the first time, that cytoplasmic expression of Programmed Cell Death Protein 4 PDCD4; a known target of mir-21) was significantly lower in women with invasive cervical carcinoma (ICC) in comparison to those with cervical intraepithelial neoplasia (2-3) or carcinoma in situ (CIN2-3/CIS), although there was no significant correlation between mir-21 and PDCD4 expression, despite previous studies identifying PDCD4 transcript as a known mir-21 target.
Whilst microRNA biomarkers have a number of promising features, more studies on expression levels in histologically defined clinical specimens are required to investigate clinical relevance of discovery-based studies. Mir-21 may be of some utility in predictive screening, given that we observed a significant correlation between mir-21 expression level and worsening histological diagnosis of cervical cancer.
微小 RNA 表达在癌变过程中受到严重干扰,然而,在人类临床癌症标本中验证细胞系模型结果的证据有限。微小 RNA-21(mir-21)和微小 RNA-143(mir-143)以前在多种癌症中被发现存在显著失调,包括宫颈癌。我们的目标是研究几种经过充分研究的微小 RNA 物种在宫颈样本中的表达模式,并将结果与细胞系样本进行比较。
方法/主要发现:我们测量了 142 个来自塞内加尔达喀尔 Dantec 肿瘤学诊所的福尔马林固定、石蜡包埋(FFPE)宫颈活检组织块中 mir-21 和 mir-143 的表达。使用 Taqman 基于实时 PCR 检测进行微 RNA 表达分析。还对 72 个样本进行了蛋白质免疫组织化学染色,以研究靶蛋白的表达。我们发现 mir-21 的表达随着临床诊断的恶化而增加,但 mir-143 与组织学无关。这些观察结果与涉及宫颈癌细胞系的先前报告形成鲜明对比,在这些报告中,mir-143 始终被下调,但 mir-21 基本不受影响。我们还首次发现,已知 mir-21 靶标的程序性细胞死亡蛋白 4(PDCD4)的细胞质表达在浸润性宫颈癌(ICC)妇女中明显低于宫颈上皮内瘤变(2-3)或原位癌(CIN2-3/CIS)患者,尽管 mir-21 与 PDCD4 表达之间没有显著相关性,尽管先前的研究确定 PDCD4 转录物是已知的 mir-21 靶标。
虽然微 RNA 生物标志物具有许多有前途的特征,但需要对组织学定义的临床标本中的表达水平进行更多研究,以研究基于发现的研究的临床相关性。鉴于我们观察到 mir-21 表达水平与宫颈癌组织学诊断恶化之间存在显著相关性,mir-21 可能在预测性筛查中具有一定的实用性。